A particular interest has been generated in the MTHFD2 enzyme as it is oncofetal, being expressed during early embryogenesis, silenced in adult cells and then re‐expressed in transformed cancer cells, making it an attractive anticancer target. The gene discussed is MTHFD2; the disease is cancer.